Results 181 to 190 of about 86,601 (293)

The ratio of brain to liver glucose activity and prognosis with CAR-T in non-Hodgkin lymphoma. [PDF]

Blood Cancer J
Dingli S, Rothweiler P, Ansell SM, Bennani NN, Durani U, Johnston PB, Khurana A, Paludo J, Villasboas Bisneto JC, Wang Y, Lin Y, Young JR, Broski SM, Erdman AG, Dingli D.   +14 more
europepmc   +1 more source

Widespread use of complementary and alternative medicine among non-Hodgkin lymphoma survivors

, 2014
Sarah Rausch Osian, Alexis D. Leal, Cristine Allmer, Matthew J. Maurer, Grezegorz Nowakowski, David J. Inwards, William R. Macon, Shawna L. Ehlers, George J. Weiner, Thomas M. Habermann, James R. Cerhan, Carrie A. Thompson   +11 more
openalex   +2 more sources

Medical History, Lifestyle, Family History, and Occupational Risk Factors for Marginal Zone Lymphoma: The InterLymph Non-Hodgkin Lymphoma Subtypes Project [PDF]

, 2014
Paige M. Bracci, Yolanda Benavente, Jennifer Turner, Ora Paltiel, Susan L. Slager, Claire M. Vajdic, A. D. Norman, James R. Cerhan, Brian C.‐H. Chiu, Nikolaus Becker, Pierluigi Cocco, Ahmet Doǧan, Alexandra Nieters, Elizabeth A. Holly, Eleanor Kane, Karin E. Smedby, Marc Maynadié, John J. Spinelli, Eve Roman, Bengt Glimelius, Sophia Wang, Joshua N. Sampson, Lindsay M. Morton, Sílvia de Sanjosé   +23 more
openalex   +1 more source

Frontline Therapy in Diffuse Large B‐Cell Lymphoma: Evolving Standards, Biological Insights, and Future Directions

European Journal of Haematology, EarlyView.
ABSTRACT Diffuse large B‐cell lymphoma (DLBCL) remains the most common aggressive lymphoma, representing a biologically heterogeneous disease with diverse clinical behaviors. For more than two decades, R‐CHOP has been the cornerstone of frontline treatment, curing approximately two‐thirds of patients.
Mamdouh Skafi, Santino Caserta, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Maria Eugenia Alvaro, Fortunato Morabito, Enrica Antonia Martino, Massimo Gentile   +12 more
wiley   +1 more source

Trends and disparities in Non-Hodgkin Lymphoma related mortality in the United States, 1999-2020. [PDF]

PLoS One
Saad M, Aisha E, Sohail MU, Sajid M, Ahmed SZ, Ibrahim ZS, Waqas SA, Aamer H, Makda FA, Aamir J, Afridi MK, Ahmed R.   +11 more
europepmc   +1 more source

Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium [PDF]

, 2015
Andrea ’t Mannetje, Anneclaire J. De Roos, Paolo Boffetta, Roel Vermeulen, Geza Benke, Lin Fritschi, Paul Brennan, Lenka Foretová, Marc Maynadié, Nikolaus Becker, Alexandra Nieters, Anthony Staines, Marcello Campagna, Brian C.‐H. Chiu, Jacqueline Clavel, Sílvia de Sanjosé, Patricia Hartge, Elizabeth A. Holly, Paige M. Bracci, Martha S. Linet, Alain Monnereau, Laurent Orsi, Mark P. Purdue, Nathaniel Rothman, Qing Lan, Eleanor Kane, Adele Seniori Costantini, Lucia Miligi, John J. Spinelli, Tongzhang Zheng, Pierluigi Cocco, Anne Kricker   +31 more
openalex   +1 more source

Silent pressure: Unveiling spinal lymphoma in horses and its parallels to other species

Equine Veterinary Education, EarlyView.
Summary Though the nervous system is an uncommon location for lymphoma, the disease should remain a differential diagnosis in some cases of ataxia in equids. Diagnosis of lymphoma can be challenging, although a combination of cytology, histopathology and immunophenotyping can aid in definitive diagnosis and therefore more accurately guide treatment and
H. E. Taylor, D. Luethy
wiley   +1 more source

Next‐generation sequencing‐based IG clonality analysis to discriminate reactive infiltrates from minimal lymphoma involvement in paired lymphoma and bone marrow biopsies; a EuroClonality‐NGS Working Group study

Histopathology, EarlyView.
Next‐generation sequencing (NGS) immunoglobulin clonality analysis can help resolve ambiguous bone marrow staging biopsies for B‐cell lymphoma. In this study, paired analysis of the primary lymphoma and bone marrow helped to detect lymphoma involvement in cases with inconclusive morphology and immunohistochemistry, making it a valuable tool for ...
Michiel van den Brand, Meilinde Leenders, Jos Rijntjes, Jeroen A.C.W. Luijks, Anton W. Langerak, Konnie M. Hebeda, Patricia J.T.A. Groenen   +6 more
wiley   +1 more source

The Potential of the Gut Microbiota and Butyrate to Enhance CAR T-cell Therapy in Non-Hodgkin Lymphoma. [PDF]

Clin Cancer Res
García-Vicente R, Rodríguez-García A, Ancos-Pintado R, Arroyo A, Ortega-Hernández A, Bragado-García I, Castellano E, Ortiz-Ruiz A, Navarro-Aguadero MÁ, Modrego J, Leivas A, García-Villalba R, Tomás-Barberán FA, Sánchez-Pina JM, Alonso R, Cedena MT, Hernández-Sánchez M, Carpio C, Barba P, Carbonell D, Kwon M, Bastos-Oreiro M, Martín García-Sancho A, Jiménez-Ubieto A, Valeri A, Gómez-Garre D, Martínez-López J, Linares M.   +27 more
europepmc   +1 more source

Prognostic significance of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, platelet/neutrophil ratio, and mean platelet volume in patients diagnosed with Hodgkin and Non-Hodgkin Lymphoma

, 2020
Mesut Göçer, Erdal Kurtoğlu
openalex   +2 more sources